2023 annual financial data
Vir Biotechnology 2023 Net margin
Direct answer
Net margin was -713.69%.
Operating income was -684,305,000 USD and net income was -615,061,000 USD.
Operating cash flow was -778,785,000 USD.
Get free Vir Biotechnology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 86,180,000 USD
- Operating income
- -684,305,000 USD
- Net income
- -615,061,000 USD
- Operating cash flow
- -778,785,000 USD